Genelabs Technologies genelabs.com


Public lists: Pharma Startups (6570)

is discovering compounds that selectively inhibit replication of the hepatitis C virus, and advancing preclinical development of compounds from this hepatitis C virus drug discovery program, while also developing a late-stage product for lupus. They aim to generate either first-in-class or best-in-class products that will address diseases for which current therapies are inadequate.

is discovering compounds that selectively inhibit replication of the hepatitis C virus, and advancing preclinical development of compounds from this hepatitis C virus drug discovery program, while also developing a late-stage product for lupus. They ...Show all

Company (Alive / Active)

Phone: 650-369-9500

Fax:

505 Penobscot Drive
Redwood City, 94063
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Genelabs Technologies $17.6M Feb 19, 2007
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Genelabs Technologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 18 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Xenon Pharmaceuticals

Burnaby, British Columbia, Canada
IPO / Went publicXenon Pharmaceuticals is a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications that we intend to commercialize on our own, and for larger market indications that we intend to partner with global pharmaceutical industry leaders. The company has built a core platform, Extreme Genetics, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mut...Show allLogin to see details

Active Pass Pharmaceuticals

British Columbia, Canada
Alive / ActiveActive Pass is a Canadian biotechnology company that is engaging in genomic-based drug discovery and is developing drugs that inhibit ABC transporters. ABC or (ATP binding cassette) is a term that describes the interconnected group of molecular engines or pumps that function as a transportation system which moves compounds across the biological membranes. These ABCs are very closely associated with human diseases like Alzheimer's disease, diabetes, asthma, and hypertension. The Active Pass mana...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Treatment of subnormal bone mineral density Dec 28, 2004 Nov 03, 2009 Patent
Bicyclic heteroaryl derivatives Jul 30, 2004 Mar 31, 2009 Patent